Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice

被引:99
作者
Liu, XQ [1 ]
Gershenfeld, HK [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA
关键词
behavioral despair; antidepressants; imipramine; inbred mice; tail suspension test; transgenic;
D O I
10.1016/S0006-3223(00)01028-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The tail suspension test (TST) is a simple screening test for the behavioral effects of antidepressants in rodents. This experiment investigated the interindividual differences in responses to stressful situations measured by duration of immobility in the TST and the effects of imipramine (30 mg/kg intraperitoneally) in reducing immobility among 11 inbred strains of mice. The 11 inbred strains were 129S6/SvEvTac, A/J, AKR/J, Balb/cJ, C3H/HeJ, C57BL/6J, DBA/2J, FVB/NJ, NMR1, SencarA/PtJ, and SWR/J. Methods: All mice underwent two trials of TST: 1) spontaneous, basal TST and 2) imipramine or saline TST. The duration of immobility was the trait measured during a 6-min test. Results: In the four strains tested, female mice had longer duration of immobility than male mice in basal TST duration of immobility. For male mice (n = 11 strains), significant strain differences in immobility duration were found for both basal TST and imipramine response TST, with heritability estimates of .31 and .60, respectively. Immobility duration for the DBA/2J, FVB/NJ, and NMRI strains were significantly reduced by imipramine, relative to saline. Surprisingly, this reduction of immobility by imipramine was independent of the basal immobility. Conclusions: These results suggest that the responses on basal TST and the imipramine-mediated responses on TST are mediated by separate genetic pathways. Biol Psychiatry 2001;49:575-581 (C) 2001 Society of Biological Psychiatry.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 49 条
[1]   DEPRESSION AS A CONSEQUENCE OF INADEQUATE NEUROCHEMICAL ADAPTATION IN RESPONSE TO STRESSORS [J].
ANISMAN, H ;
ZACHARKO, RM .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :36-43
[2]  
ATCHLEY WR, 1993, MOL BIOL EVOL, V10, P1150
[3]   GAS CHROMATOGRAPHIC-MASS FRAGMENTOGRAPHIC DETERMINATION OF STEADY-STATE PLASMA-LEVELS OF IMIPRAMINE AND DESIPRAMINE IN CHRONICALLY TREATED PATIENTS [J].
BELVEDERE, G ;
BURTI, L ;
FRIGERIO, A ;
PANTAROTTO, C .
JOURNAL OF CHROMATOGRAPHY, 1975, 111 (02) :313-321
[4]   INFLUENCE OF OVARIECTOMY, ESTRADIOL AND PROGESTERONE ON THE BEHAVIOR OF MICE IN AN EXPERIMENTAL-MODEL OF DEPRESSION [J].
BERNARDI, M ;
VERGONI, AV ;
SANDRINI, M ;
TAGLIAVINI, S ;
BERTOLINI, A .
PHYSIOLOGY & BEHAVIOR, 1989, 45 (05) :1067-1068
[5]   Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review [J].
Bonhomme, N ;
Esposito, E .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :447-454
[6]   Mouse mutagenesis - systematic studies of mammalian gene function [J].
Brown, SDM ;
Nolan, PM .
HUMAN MOLECULAR GENETICS, 1998, 7 (10) :1627-1633
[7]  
CHERMAT R, 1986, J PHARMACOL-PARIS, V17, P348
[8]   DRUG-TREATMENT OF PANIC DISORDER - COMPARATIVE EFFICACY OF ALPRAZOLAM, IMIPRAMINE, AND PLACEBO [J].
COLEMAN, JH ;
KLERMAN, GL ;
AYUSO, JL ;
BECH, P ;
BENKERT, O ;
BRANDON, S ;
CASSANO, GB ;
SILVA, JACE ;
CURTIS, GC ;
DELAFUENTE, JR ;
GUIMON, J ;
HIPPIUS, H ;
LECRUBIER, Y ;
LEON, CA ;
LOPEZIBOR, JJ ;
KATSCHNIG, H ;
MASSANA, J ;
MELLERGAARD, M ;
OTTOSON, JO ;
RAFAELSEN, OJ ;
ROSENBERG, R ;
ROTH, M ;
SEPULVEDA, J ;
SOLYOM, L ;
VERSIANI, M ;
WILMOTTE, J .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :191-202
[9]   Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies [J].
Crawley, JN ;
Belknap, JK ;
Collins, A ;
Crabbe, JC ;
Frankel, W ;
Henderson, N ;
Hitzemann, RJ ;
Maxson, SC ;
Miner, LL ;
Silva, AJ ;
Wehner, JM ;
WynshawBoris, A ;
Paylor, R .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :107-124
[10]  
DINGELL JV, 1964, J PHARMACOL EXP THER, V143, P14